97 related articles for article (PubMed ID: 24268998)
1. Autoantibodies in primary biliary cirrhosis: antinuclear envelope autoantibodies.
Chantran Y; Ballot E; Johanet C
Clin Res Hepatol Gastroenterol; 2014 Jun; 38(3):256-8. PubMed ID: 24268998
[No Abstract] [Full Text] [Related]
2. Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis.
Bogdanos DP; Liaskos C; Pares A; Norman G; Rigopoulou EI; Caballeria L; Dalekos GN; Rodes J; Vergani D
Hepatology; 2007 Jun; 45(6):1583; author reply 1583-4. PubMed ID: 17538935
[No Abstract] [Full Text] [Related]
3. [Nuclear envelope autoantibodies and liver diseases].
Zinelabidine Y; Lassoued K; André C; Dhumeaux D
Gastroenterol Clin Biol; 1990; 14(4):319-23. PubMed ID: 2190854
[No Abstract] [Full Text] [Related]
4. Primary biliary cirrhosis and the molecular cell biology of the nuclear envelope.
Worman HJ
Mt Sinai J Med; 1994 Nov; 61(6):461-75. PubMed ID: 7838161
[TBL] [Abstract][Full Text] [Related]
5. Nuclear envelope protein autoantibodies in primary biliary cirrhosis.
Courvalin JC; Worman HJ
Semin Liver Dis; 1997 Feb; 17(1):79-90. PubMed ID: 9089913
[TBL] [Abstract][Full Text] [Related]
6. [Antinuclear antibodies in primary biliary cirrhosis].
Mzali S; Johanet C; Chrétien P; Abuaf N
Gastroenterol Clin Biol; 1989; 13(8-9):690-5. PubMed ID: 2680726
[TBL] [Abstract][Full Text] [Related]
7. Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients.
Sfakianaki O; Koulentaki M; Tzardi M; Tsangaridou E; Theodoropoulos PA; Castanas E; Kouroumalis EA
World J Gastroenterol; 2010 Oct; 16(39):4938-43. PubMed ID: 20954280
[TBL] [Abstract][Full Text] [Related]
8. Liver diseases associated with autoantibodies directed to nuclear envelope components.
Lassoued K; Danon F; André C; Courvalin JC; Dhumeaux D
Hepatology; 1989 Jun; 9(6):911-2. PubMed ID: 2653997
[No Abstract] [Full Text] [Related]
9. Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis.
Lassoued K; Brenard R; Degos F; Courvalin JC; Andre C; Danon F; Brouet JC; Zine-el-Abidine Y; Degott C; Zafrani S
Gastroenterology; 1990 Jul; 99(1):181-6. PubMed ID: 2188869
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis.
Lozano F; Parés A; Borche L; Plana M; Gallart T; Rodés J; Vives J
Hepatology; 1988; 8(4):930-8. PubMed ID: 3292364
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to 200 kD polypeptide(s) of the nuclear envelope: a new serologic marker of primary biliary cirrhosis.
Lassoued K; Guilly MN; Andre C; Paintrand M; Dhumeaux D; Danon F; Brouet JC; Courvalin JC
Clin Exp Immunol; 1988 Nov; 74(2):283-8. PubMed ID: 3066540
[TBL] [Abstract][Full Text] [Related]
12. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore.
Courvalin JC; Lassoued K; Bartnik E; Blobel G; Wozniak RW
J Clin Invest; 1990 Jul; 86(1):279-85. PubMed ID: 2195063
[TBL] [Abstract][Full Text] [Related]
13. Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies.
Wesierska-Gadek J; Klima A; Komina O; Ranftler C; Invernizzi P; Penner E
Ann N Y Acad Sci; 2007 Aug; 1109():519-30. PubMed ID: 17785341
[TBL] [Abstract][Full Text] [Related]
14. Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study.
Miyachi K; Hankins RW; Matsushima H; Kikuchi F; Inomata T; Horigome T; Shibata M; Onozuka Y; Ueno Y; Hashimoto E; Hayashi N; Shibuya A; Amaki S; Miyakawa H
J Autoimmun; 2003 May; 20(3):247-54. PubMed ID: 12753810
[TBL] [Abstract][Full Text] [Related]
15. [Investigating the relationship between anti-gp210 antibody and clinical basic profile of primary billiary cirrhosis].
Yang J; Yang JH; You LY; Xu ZY; Yang LH
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):468-9. PubMed ID: 19567032
[No Abstract] [Full Text] [Related]
16. Clinical significance of autoantibodies directed against nuclear and cytoplasmic antigens in autoimmune liver disease.
McLean F
Br J Biomed Sci; 2013; 70(1):10-4. PubMed ID: 23617092
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of anti-gp210 antibodies in primary biliary cirrhosis: a case-based review.
Valour F; Durupt S; Khenifer S; Durieu I
BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23814122
[TBL] [Abstract][Full Text] [Related]
18. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.
Nakamura M; Kondo H; Mori T; Komori A; Matsuyama M; Ito M; Takii Y; Koyabu M; Yokoyama T; Migita K; Daikoku M; Abiru S; Yatsuhashi H; Takezaki E; Masaki N; Sugi K; Honda K; Adachi H; Nishi H; Watanabe Y; Nakamura Y; Shimada M; Komatsu T; Saito A; Saoshiro T; Harada H; Sodeyama T; Hayashi S; Masumoto A; Sando T; Yamamoto T; Sakai H; Kobayashi M; Muro T; Koga M; Shums Z; Norman GL; Ishibashi H
Hepatology; 2007 Jan; 45(1):118-27. PubMed ID: 17187436
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against constituents of nuclear pore complexes in patients with primary biliary cirrhosis and autoimmune hepatitis.
Wesierska-Gadek J; Hohenauer H; Hitchman E; Penner E
Acta Biochim Pol; 1995; 42(2):197-200. PubMed ID: 8588463
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210.
Nickowitz RE; Worman HJ
J Exp Med; 1993 Dec; 178(6):2237-42. PubMed ID: 7504063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
